Weight loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk

Documenti analoghi

• Response to “Weight‐loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk”
  di: Robert F. Kushner, et al.
  Pubblicazione: (2025)
• The effects of anti‐obesity medications on bone metabolism: A critical appraisal
  di: Athanasios D. Anastasilakis, et al.
  Pubblicazione: (2025)
• Fracture risk revisited: Bone mineral density T‐score and fracture risk in type 2 diabetes
  di: V. Van Hulten, et al.
  Pubblicazione: (2024)
• The association of type 2 diabetes‐related characteristics with fracture risk at different sites
  di: Veerle van Hulten, et al.
  Pubblicazione: (2024)
• Factors that shape dietary intake in children in the context of increasing risk for obesity development
  di: Michael I. Goran, et al.
  Pubblicazione: (2025)